Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Oct;52(10):2457–2467. doi: 10.1172/JCI107437

Inhibition of Primary ADP-Induced Platelet Aggregation in Normal Subjects after Administration of Nitrofurantoin (Furadantin)

Ennio C Rossi 1, Nathan W Levin 1
PMCID: PMC302505  PMID: 4729043

Abstract

The evidence indicating that platelets may play a role in the occurrence of certain thromboembolic phenomena has stimulated a search for inhibitors of platelet function. This report presents data to indicate that nitrofurantoin is a potent inhibitor of primary ADP-induced platelet aggregation. The addition of 10 μM nitrofurantoin to citrated platelet-rich plasma obtained from 12 normal subjects produced a 29±6% (2 SD) inhibition of the velocity of platelet aggregation induced by 2 μM ADP. The inhibitory effect of nitrofurantoin demonstrated competitive kinetics in respect to ADP. The intravenous (180 mg) or oral (200 mg) administration of nitrofurantoin produced a serum nitrofurantoin concentration ranging from 2.7 to 23 μM in 28 normal subjects. Platelet-rich plasma obtained from these subjects demonstrated inhibition of the velocity of ADP-induced platelet aggregation that correlated with the log of the serum nitrofurantoin concentration (P < 0.001). Collagen-induced platelet aggregation was also inhibited in a dose-related manner, and the bleeding time was significantly prolonged in the two subjects with the highest serum nitrofurantoin concentration. These studies indicate that nitrofurantoin in vivo inhibits platelet function to a degree that is proportional to the serum nitrofurantoin concentration.

Full text

PDF
2457

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdulla Y. H. Beta-adrenergic receptors in human platelets. J Atheroscler Res. 1969 Mar-Apr;9(2):171–177. doi: 10.1016/s0368-1319(69)80052-9. [DOI] [PubMed] [Google Scholar]
  2. BEAUMONT J. L., CAEN J., BERNARD J. Influence de l'acide acétyl salicylique dans les maladies hémorragiques. Sang. 1956;27(3):243–248. [PubMed] [Google Scholar]
  3. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  4. BORN G. V., CROSS M. J. THE AGGREGATION OF BLOOD PLATELETS. J Physiol. 1963 Aug;168:178–195. doi: 10.1113/jphysiol.1963.sp007185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BORN G. V., HONOUR A. J., MITCHELL J. R. INHIBITION BY ADENOSINE AND BY 2-CHLOROADENOSINE OF THE FORMATION AND EMBOLIZATION OF PLATELET THROMBI. Nature. 1964 May 23;202:761–765. doi: 10.1038/202761a0. [DOI] [PubMed] [Google Scholar]
  6. BOUNAMEAUX Y. [The coupling of platelets with subendothelial fibers]. C R Seances Soc Biol Fil. 1959;153:865–867. [PubMed] [Google Scholar]
  7. BRECHER G., CRONKITE E. P. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950 Dec;3(6):365–377. doi: 10.1152/jappl.1950.3.6.365. [DOI] [PubMed] [Google Scholar]
  8. BUZARD J. A., CONKLIN J. D., O'KEEFE E., PAUL M. F. Studies on the absorption, distribution and elimination of nitrofurantoin in the rat. J Pharmacol Exp Ther. 1961 Jan;131:38–43. [PubMed] [Google Scholar]
  9. Ball G., Brereton G. G., Fulwood M., Ireland D. M., Yates P. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate. Biochem J. 1970 Dec;120(4):709–718. doi: 10.1042/bj1200709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Born G. V. Research on haemostasis: some urgent questions. Med Clin North Am. 1972 Jan;56(1):3–8. doi: 10.1016/s0025-7125(16)32417-8. [DOI] [PubMed] [Google Scholar]
  11. Bowie E. J., Owen C. A., Jr, Thompson J. H., Didisheim P. Platelet adhesiveness in von Willebrand's disease. Am J Clin Pathol. 1969 Jul;52(1):69–77. doi: 10.1093/ajcp/52.1.69. [DOI] [PubMed] [Google Scholar]
  12. Carlson L. A., Irion E., Orö L. Effect of infusion of prostaglandin E1 on the aggregation of blood platelets in man. Life Sci. 1968 Jan 1;7(1):85–90. doi: 10.1016/0024-3205(68)90365-2. [DOI] [PubMed] [Google Scholar]
  13. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of dipyridamole on human platelet behaviour. Lancet. 1965 Sep 25;2(7413):603–606. doi: 10.1016/s0140-6736(65)90515-5. [DOI] [PubMed] [Google Scholar]
  14. Felts J. H., Hayes D. M., Gergen J. A., Toole J. F. Neural, hematologic and bacteriologic effects of nitrofurantoin in renal insufficiency. Am J Med. 1971 Sep;51(3):331–339. doi: 10.1016/0002-9343(71)90268-3. [DOI] [PubMed] [Google Scholar]
  15. GAARDER A., JONSEN J., LALAND S., HELLEM A., OWREN P. A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature. 1961 Nov 11;192:531–532. doi: 10.1038/192531a0. [DOI] [PubMed] [Google Scholar]
  16. GAST L. F. INFLUENCE OF ASPIRIN ON HAEMOSTATIC PARAMETERS. Ann Rheum Dis. 1964 Nov;23:500–504. doi: 10.1136/ard.23.6.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Giromini M., Bouvier C. A., Dami R., Denizot M., Jeannet M. Effect of dipyridamole and aspirin in thrombotic microangiopathy. Br Med J. 1972 Feb 26;1(5799):545–546. doi: 10.1136/bmj.1.5799.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. HOVIG T. RELEASE OF A PLATELET-AGGREGATING SUBSTANCE (ADENOSINE DIPHOSPHATE) FROM RABBIT BLOOD PLATELETS INDUCED BY SALINE "EXTRACT" OF TENDONS. Thromb Diath Haemorrh. 1963 Jul 15;143:264–278. [PubMed] [Google Scholar]
  19. HUGUES J. [Binding of platelets to collagen]. C R Seances Soc Biol Fil. 1960;154:866–868. [PubMed] [Google Scholar]
  20. Harker L. A., Slichter S. J. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med. 1970 Dec 10;283(24):1302–1305. doi: 10.1056/NEJM197012102832402. [DOI] [PubMed] [Google Scholar]
  21. Michal F., Maguire M. H., Gough G. 2-methylthioadenosine-5'-phosphate: a specific inhibitor of platelet aggregation. Nature. 1969 Jun 14;222(5198):1073–1074. doi: 10.1038/2221073a0. [DOI] [PubMed] [Google Scholar]
  22. Mielke C. H., Jr, Kaneshiro M. M., Maher I. A., Weiner J. M., Rapaport S. I. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood. 1969 Aug;34(2):204–215. [PubMed] [Google Scholar]
  23. O'Brien J. R. Effects of salicylates on human platelets. Lancet. 1968 Apr 13;1(7546):779–783. doi: 10.1016/s0140-6736(68)92228-9. [DOI] [PubMed] [Google Scholar]
  24. Packham M. A., Warrior E. S., Glynn M. F., Senyi A. S., Mustard J. F. Alteration of the response of platelets to surface stimuli by pyrazole compounds. J Exp Med. 1967 Jul 1;126(1):171–188. doi: 10.1084/jem.126.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Quick A. J. Salicylates and bleeding: the aspirin tolerance test. Am J Med Sci. 1966 Sep;252(3):265–269. doi: 10.1097/00000441-196609000-00003. [DOI] [PubMed] [Google Scholar]
  26. RICHARDS W. A., RISS E., KASS E. H., FINLAND M. Nitrofurantoin; clinical and laboratory studies in urinary tract infections. AMA Arch Intern Med. 1955 Oct;96(4):437–450. doi: 10.1001/archinte.1955.00250150011001. [DOI] [PubMed] [Google Scholar]
  27. Rossi E. C., Green D. A study of platelet retention by glass bead columns ('platelet adhesiveness' in normal subjects). Br J Haematol. 1972 Jul;23(1):47–57. doi: 10.1111/j.1365-2141.1972.tb03458.x. [DOI] [PubMed] [Google Scholar]
  28. Rossi E. C., Levin N. W. Inhibition of ADP-induced platelet aggregation by furosemide. J Lab Clin Med. 1973 Jan;81(1):140–147. [PubMed] [Google Scholar]
  29. SMYTHE H. A., OGRYZLO M. A., MURPHY E. A., MUSTARD J. F. THE EFFECT OF SULFINPYRAZONE (ANTURAN) ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN. Can Med Assoc J. 1965 Apr 10;92:818–821. [PMC free article] [PubMed] [Google Scholar]
  30. SPAET T. H., ZUCKER M. B. MECHANISM OF PLATELET PLUG FORMATION AND ROLE OF ADENOSINE DIPHOSPHATE. Am J Physiol. 1964 Jun;206:1267–1274. doi: 10.1152/ajplegacy.1964.206.6.1267. [DOI] [PubMed] [Google Scholar]
  31. Salzman E. W., Harris W. H., DeSanctis R. W. Reduction in venous thromboembolism by agents affecting platelet function. N Engl J Med. 1971 Jun 10;284(23):1287–1292. doi: 10.1056/NEJM197106102842303. [DOI] [PubMed] [Google Scholar]
  32. Skoza L., Zucker M. B., Jerushalmy Z., Grant R. Kinetic studies of platelet aggregation induced by adenosine diphosphate and its inhibition by chelating agents, guanidino compounds, and adenosine. Thromb Diath Haemorrh. 1967 Dec 31;18(3-4):713–725. [PubMed] [Google Scholar]
  33. Sullivan J. M., Harken D. E., Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N Engl J Med. 1971 Jun 24;284(25):1391–1394. doi: 10.1056/NEJM197106242842501. [DOI] [PubMed] [Google Scholar]
  34. Weiss H. J., Aledort L. M. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967 Sep 2;2(7514):495–497. doi: 10.1016/s0140-6736(67)91658-3. [DOI] [PubMed] [Google Scholar]
  35. Weiss H. J., Aledort L. M., Kochwa S. The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest. 1968 Sep;47(9):2169–2180. doi: 10.1172/JCI105903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wolfe S. M., Shulman N. R. Adenyl cyclase activity in human platelets. Biochem Biophys Res Commun. 1969 Apr 29;35(2):265–272. doi: 10.1016/0006-291x(69)90277-0. [DOI] [PubMed] [Google Scholar]
  37. Zacharski L. R., Walworth C., McIntyre O. R. Antiplatelet therapy for thrombotic thrombocytopenic purpura. N Engl J Med. 1971 Aug 12;285(7):408–409. doi: 10.1056/NEJM197108122850717. [DOI] [PubMed] [Google Scholar]
  38. Zucker M. B., Peterson J. Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets. J Lab Clin Med. 1970 Jul;76(1):66–75. [PubMed] [Google Scholar]
  39. Zucker M. B., Peterson J. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc Soc Exp Biol Med. 1968 Feb;127(2):547–551. doi: 10.3181/00379727-127-32737. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES